OnTrack Logo

To find information on KIMMTRAK▼ (Tebentafusp) you can access the following external links to the Electronic Medicines Compendium (eMC)where Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) are hosted.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects that you may get.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

This website is owned and developed by Immunocore Ltd.
Job Code: PM-EU-KIM-2500003, DOP: April 2026

Cookie Statement

Manage Cookie Preferences

You are now leaving an Immunocore website. Immunocore is not responsible for the content, except where it has supplied or reviewed the content, availability, or terms of use of third-party sites, and accepts no liability for any loss or damage resulting from their use. Please review the legal and privacy policies of any site you visit.